Follow-up schedule for patients with sentinel node–negative cutaneous melanoma (The MELFO Study). An international phase III randomized clinical trial.
Moncrieff MD, Bastiaannet E, Underwood B, Francken AB, Garioch J, Damude S et al.
Ann Surg 2022; 276: e208-e216.
Some 388 patients were enrolled into a study comparing standard follow-up with a reduced frequency schedule. There was no difference in recurrence rates between the groups. Three quarters of patients in both groups found their recurrence by self-examination.
Comment: Routine follow-up may not help patients with melanoma; perhaps an approach teaching them self-examination would be better.
17 November 2022
Read paperAcademy
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
